Shafeeq Ladha
Director · Barrow Neurological Institute at St Joseph's Hospital and Medical Center
Credentials: · · · ·
History
- Present
Muscular Dystrophy Center · University of Arizona College of Medicine - Phoenix
- 2007–2008
Clinical Neurophysiology
2006–2007- 2001–2004
Barrow Neurological Institute and St Joseph's Hospital and Medical Center
- 2000–2001
Saint Joseph's Hospital and Medical Center
Research
Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
New England Journal of Medicine · 2020 · 460 citations
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
New England Journal of Medicine · 2020 · 415 citations
The Lancet · 2014 · 219 citations
15 papers
15 papers
14 papers
14 papers
14 papers
13 papers · 1 as a fellow
- DH
12 papers
- JK
12 papers
Clinical trials
- 2017–2021
Deep Phenotyping in Patients With ALS
Principal investigator · Completed
Barrow Neurological Institute
- 2015–2018
A Trial of Tocilizumab in ALS Subjects
Principal investigator · Completed · Phase 2
Barrow Neurological Institute
- 2026–2032
Site PI · Recruiting · Phase 1, Phase 2
AskBio Inc
- 2025–2027
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Site PI · Recruiting · Phase 1, Phase 2
Vector Y Therapeutics